Anteris Technologies Launches $35m capital raise as FDA approves DurAVR study
Anteris Technologies (AVR) launches a $35 million capital raise for the clinical development...
Anteris Technologies Reports positive data from first-in-human heart valve trial
Meditech specialist Anteris Technologies (ARV) reports “excellent” results from the first-in-human trial of its...